The expression of p53 protein in patients with multiple myeloma
Introduction: Although mutations of p53 are one of the most often acquired genetic changes in malignant tumors, these mutations are rare events in patients with newly diagnosed multiple myeloma (MM). Moreover, there are a few literature data about clinical significance of p53 overexpression in multi...
Main Authors: | Marković Olivera, Marisavljević Dragomir, Čemerikić Vesna, Peruničić Maja, Čolović Milica |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2007-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2007/0370-81790702043M.pdf |
Similar Items
-
Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
by: Marković Olivera, et al.
Published: (2005-01-01) -
The prognostic role of p-53 protein Immunohistochemical expression in multiple myeloma
by: Muna A. Abdullah, et al.
Published: (2015-01-01) -
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
by: Jahangir Abdi, et al.
Published: (2017-10-01) -
Clinical implications of c-maf expression in plasma cells from patients with multiple myeloma
by: GuoQing Wei, et al.
Published: (2017-05-01) -
High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment
by: Halina Urbanska-Rys, et al.
Published: (2003-01-01)